Cargando…

Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017

BACKGROUND: Colorectal mucosa-associated lymphoid tissue (MALT) lymphoma (cMALToma) is rare and comprises only 2.5% of the MALT lymphomas. Its etiology and treatment have not been well established. The aim of this systematic literature review was to try to characterize cMALToma and analyze the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Jae Hee, Kim, Sung Min, Kim, Jong Wan, Park, Jun Ho, Kim, Jeong Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759223/
https://www.ncbi.nlm.nih.gov/pubmed/31572011
http://dx.doi.org/10.2147/CMAR.S214197
_version_ 1783453660457467904
author Won, Jae Hee
Kim, Sung Min
Kim, Jong Wan
Park, Jun Ho
Kim, Jeong Yeon
author_facet Won, Jae Hee
Kim, Sung Min
Kim, Jong Wan
Park, Jun Ho
Kim, Jeong Yeon
author_sort Won, Jae Hee
collection PubMed
description BACKGROUND: Colorectal mucosa-associated lymphoid tissue (MALT) lymphoma (cMALToma) is rare and comprises only 2.5% of the MALT lymphomas. Its etiology and treatment have not been well established. The aim of this systematic literature review was to try to characterize cMALToma and analyze the risk factors for treatment failure with various therapeutic strategies. METHODS: We retrospectively reviewed 50 case reports from 1993 to 2017 through a PubMed search of English medical literature, describing cMALToma. We included 67 patients from previous case reports and we added 6 patients treated for cMALToma in our multicenter institutes. Risk factor analysis was done for treatment failure, defined as remission failure and recurrence. RESULTS: Of 73 patients diagnosed with cMALToma, tumors were located in 54 patients (74.0%) in the rectum, in 10 patients (13.6%) in the right colon, in 3 patients (4.1%) in the transverse colon, and in 6 patients (8.2%) in the sigmoid colon. In first-line treatment, patients achieved complete remission (CR) with surgery (18/19 cases), local resection (18/19 cases), chemotherapy (12/13 cases), radiation therapy (4/5 cases), antibiotics therapy including Helicobacter pylori eradication (12/15 cases), and no treatment (1/2 cases). Among these, eight cases (10.9%) needed second-line treatment, and there was overall remission failure in 3 cases (4.1%). Of the remaining 70 patients with CR, the tumor recurred in 5 patients (6.8%). The multivariable analysis showed that male sex, multiple tumors, and first-line treatment failure were significantly related to treatment failure (p=0.03, p=0.05, p=0.03, respectively). CONCLUSION: CR of primary cMALToma was achieved using various therapeutic strategies. First-line treatment failure and multiple tumors were associated with treatment failure, although the numbers of cases that failed are too small to draw definitive conclusions.
format Online
Article
Text
id pubmed-6759223
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67592232019-09-30 Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017 Won, Jae Hee Kim, Sung Min Kim, Jong Wan Park, Jun Ho Kim, Jeong Yeon Cancer Manag Res Original Research BACKGROUND: Colorectal mucosa-associated lymphoid tissue (MALT) lymphoma (cMALToma) is rare and comprises only 2.5% of the MALT lymphomas. Its etiology and treatment have not been well established. The aim of this systematic literature review was to try to characterize cMALToma and analyze the risk factors for treatment failure with various therapeutic strategies. METHODS: We retrospectively reviewed 50 case reports from 1993 to 2017 through a PubMed search of English medical literature, describing cMALToma. We included 67 patients from previous case reports and we added 6 patients treated for cMALToma in our multicenter institutes. Risk factor analysis was done for treatment failure, defined as remission failure and recurrence. RESULTS: Of 73 patients diagnosed with cMALToma, tumors were located in 54 patients (74.0%) in the rectum, in 10 patients (13.6%) in the right colon, in 3 patients (4.1%) in the transverse colon, and in 6 patients (8.2%) in the sigmoid colon. In first-line treatment, patients achieved complete remission (CR) with surgery (18/19 cases), local resection (18/19 cases), chemotherapy (12/13 cases), radiation therapy (4/5 cases), antibiotics therapy including Helicobacter pylori eradication (12/15 cases), and no treatment (1/2 cases). Among these, eight cases (10.9%) needed second-line treatment, and there was overall remission failure in 3 cases (4.1%). Of the remaining 70 patients with CR, the tumor recurred in 5 patients (6.8%). The multivariable analysis showed that male sex, multiple tumors, and first-line treatment failure were significantly related to treatment failure (p=0.03, p=0.05, p=0.03, respectively). CONCLUSION: CR of primary cMALToma was achieved using various therapeutic strategies. First-line treatment failure and multiple tumors were associated with treatment failure, although the numbers of cases that failed are too small to draw definitive conclusions. Dove 2019-09-20 /pmc/articles/PMC6759223/ /pubmed/31572011 http://dx.doi.org/10.2147/CMAR.S214197 Text en © 2019 Won et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Won, Jae Hee
Kim, Sung Min
Kim, Jong Wan
Park, Jun Ho
Kim, Jeong Yeon
Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
title Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
title_full Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
title_fullStr Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
title_full_unstemmed Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
title_short Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
title_sort clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (malt) lymphoma: literature reviews published in english between 1993 and 2017
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759223/
https://www.ncbi.nlm.nih.gov/pubmed/31572011
http://dx.doi.org/10.2147/CMAR.S214197
work_keys_str_mv AT wonjaehee clinicalfeaturestreatmentandoutcomesofcolorectalmucosaassociatedlymphoidtissuemaltlymphomaliteraturereviewspublishedinenglishbetween1993and2017
AT kimsungmin clinicalfeaturestreatmentandoutcomesofcolorectalmucosaassociatedlymphoidtissuemaltlymphomaliteraturereviewspublishedinenglishbetween1993and2017
AT kimjongwan clinicalfeaturestreatmentandoutcomesofcolorectalmucosaassociatedlymphoidtissuemaltlymphomaliteraturereviewspublishedinenglishbetween1993and2017
AT parkjunho clinicalfeaturestreatmentandoutcomesofcolorectalmucosaassociatedlymphoidtissuemaltlymphomaliteraturereviewspublishedinenglishbetween1993and2017
AT kimjeongyeon clinicalfeaturestreatmentandoutcomesofcolorectalmucosaassociatedlymphoidtissuemaltlymphomaliteraturereviewspublishedinenglishbetween1993and2017